The histone methyltransferase EZH2, the catalytic subunit of PRC2, has been confirmed to promote the trimethylation of H3K27 (H3K27me3), which is involved in the epigenetic silencing of target genes during cancer development. This evidence concerns the gene PRDM9 and cancer.